Stock 300601 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Shenzhen Kangtai Biological Products Co., Ltd.

Equities

300601

CNE100002Q33

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
17.44 CNY -0.06% Intraday chart for Shenzhen Kangtai Biological Products Co., Ltd. -2.02% -35.76%
Jun. 06 Shenzhen Kangtai Biological Products Co., Ltd. Announces Dividend Implementation (Cash Only) Payable on 14 June 2024 CI
Apr. 26 Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shenzhen Kangtai Biological Products Co., Ltd. Announces Dividend Implementation (Cash Only) Payable on 14 June 2024
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Kangtai Biological Forecasts Swing to Profit in 2023
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenzhen Kangtai Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemented (A Shares) for 2023, Payable on 13 October 2023
Shenzhen Kangtai Biological Products Co., Ltd. Approves 2023 Interim Cash Dividend
Kangtai Signs Deal to Distribute Varicella Vaccine in Pakistan, India
Shenzhen Kangtai Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Kangtai Biological Partners With Indian Drugmaker to Distribute Pneumococcal Vaccine
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shenzhen Kangtai Biological sees 2022 net loss on weaker COVID shot demand
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shenzhen Kangtai Biological Products Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 14, 2022.
China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shenzhen Kangtai Biological Products Co., Ltd. authorizes a Buyback Plan.
Kangtai Biological Sees Up to 70% Profit Slump in H1
Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on 2 June 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300601 Stock
  4. News Shenzhen Kangtai Biological Products Co., Ltd.
  5. Other languages